PharmSource - Contract Dose Manufacturing Industry by the Numbers: Composition, Size, Market Share and Outlook - 2017 Edition
Contract Dose Manufacturing universe, for purposes of this report, includes companies that actively promote themselves as contract manufacturers (CMOs) that produce a client’s formulation for pharmaceuticals supplied to the highly-regulated markets in North America, Europe and Japan. Contract dose manufacturing universe includes 282 companies headquar¬tered primarily in North America, Europe, Japan and India. One hundred and eighty-one companies (64%) pursue contract manufacturing as their primary business, while the remainder (36%) contract manufacture in facilities where they produce their own products.
Size of the dose CMO market in 2016 was $19.3 billion, a 4.0% increase from 2015. Organic growth, i.e., without the impact of acquisitions of facili¬ties from bio/ pharmaceutical companies, was 3.2%. Industry growth was also negatively impacted by facility remediation at Ferentino (Patheon) and Beinheim (Catalent). Standard dose products including solid dose, semisolid and non-injectable liquids, accounted for 51% of the market in 2016. Injectables accounted for 28% and specialty dose forms, including softgels, transdermal and blow-fill-seal, accounted for 21%.
From 2010-2014 the CMO sector grew at twice the rate of the bio/pharmaceu¬tical sector in mature markets including North America, Europe and Japan. Industry analysts expect that annual growth of the mature bio/pharmaceutical sector will be in the 2.5-3.5% range through 2019. PharmSource expects the CMO industry growth to continue to slow relative to overall industry growth despite the significant increase in New Active Substances launched from 2014 onwards. We see this primarily as a consequence of a decline in unit volume per product, while outsourcing pro¬pensity has remained stable for a decade.
The report PharmSource - Contract Dose Manufacturing Industry by the Numbers: Composition, Size, Market Share and Outlook - 2017 Edition provides an important expert quantitative analysis on the contract dose manufacturing industry. PharmSource is the most definitive, trustworthy source of strategic insight on this topic in the bio/pharmaceutical realm. Moreover, this report includes an Executive Summary and chapters on Industry Size and Structure, Industry Size and Growth, CMO Market Shares and concludes with a chapter on The Outlook for the Dose CMO Industry, which provides further analysis and assesses the report’s implications for the dose CMO industry. In addition, it includes an appendix on methodology.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook